IGEA PHARMA N.V.
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Diagnostic & Testing Substances
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 12.64B | ||||||
| 8.46B | ||||||
| 5.27B | - | - | ||||
| 4.49B | ||||||
| 3.11B | - |
